Carcinogenesis, Vol. 23, No. 3, 419-424,
March 2002
© 2002 Oxford University Press
MOLECULAR EPIDEMIOLOGY |
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma
1 Department of Health Research and Policy,
2 Department of Medicine,
3 Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA,
4 Department of Pathology and
5 Division of Research, Kaiser Permanente Medical Care Program, Oakland, CA 94611, USA,
6 Metabolism Branch, National Cancer Institute, Bethesda, MD 20892, USA and
7 Orentreich Foundation for the Advancement of Science, Inc., Cold Spring-on-Hudson, NY 10516, USA
Abstract
Infection with Helicobacter pylori (H. pylori) increases stomach cancer risk. Helicobacter pylori strains with the cag pathogenicity island (PAI) induce more severe inflammation in the gastric epithelium and are more strongly associated with stomach cancer risk than strains lacking the PAI. We examined whether the prevalence of somatic p53 mutation in gastric adenocarcinoma differed between subjects with and without infection with CagA+ (a marker for the PAI) H. pylori strains. DNA from 105 microdissected tumor specimens was analyzed for mutation in exons 5–8 of the p53 gene by polymerase chain reaction-based single-strand conformation polymorphism followed by direct DNA sequencing. Enzyme-linked immunosorbent assays for IgG antibodies against H. pylori and CagA were performed on sera collected 2–31 years prior to cancer diagnosis. Tumors from CagA+ subjects were significantly more likely to have p53 mutations than tumors from CagA- subjects (including H. pylori– and H. pylori+/CagA-): odds ratio = 3.72; 95% confidence interval, 1.06–13.07 after adjustment for histologic type and anatomic subsite of tumor and age at diagnosis and sex of subjects. Mutations were predominantly insertions and deletions (43%) as well as transition mutations at CpG dinucleotides (33%). The data suggest that CagA+ H. pylori infection, when compared with CagA- infection or the absence of H. pylori infection, is associated with a higher prevalence of p53 mutation in gastric adenocarcinoma.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. E. Landvik, K. Hart, V. Skaug, L. B. Stangeland, A. Haugen, and S. Zienolddiny A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer Carcinogenesis, July 1, 2009; 30(7): 1186 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Izzotti, S. De Flora, C. Cartiglia, B. M. Are, M. Longobardi, A. Camoirano, I. Mura, M. P. Dore, A. M. Scanu, P. C. Rocca, et al. Interplay between Helicobacter pylori and host gene polymorphisms in inducing oxidative DNA damage in the gastric mucosa Carcinogenesis, April 1, 2007; 28(4): 892 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Magalhaes, D. M.M. Queiroz, A. A. Camargo, and A. J.G. Simpson CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma Carcinogenesis, January 1, 2003; 24(1): 145 - 145. [Full Text] [PDF]
|
|
|
|
|
|
A. Shibata, J. Parsonnet, T. A. Longacre, M. I. Garcia, B. Puligandla, R. E. Davis, J. H. Vogelman, N. Orentreich, and L. A. Habel Cag A status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma Carcinogenesis, January 1, 2003; 24(1): 147 - 147. [Full Text] [PDF]
|
|